Trexquant Investment LP Neurocrine Biosciences Inc Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Trexquant Investment LP holds 99,349 shares of NBIX stock, worth $12.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

99,349

Holding current value

$12.5 Million

% of portfolio

0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $11.4 Million - $15.2 Million	99,349 New	99,349 $11.4 Million
Q1 2024 May 14, 2024	SELL	$130.4 - $143.74 $6.55 Million - $7.22 Million	-50,242 Reduced 56.99%	37,918 $5.23 Million
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $8.71 Million - $10.9 Million	82,139 Added 1364.21%	88,160 $11.6 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $566,094 - $705,059	6,021 New	6,021 $677,000
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $284,400 - $371,766	3,022 Added 5.42%	58,769 $5.95 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $5.33 Million - $6.34 Million	49,911 Added 855.23%	55,747 $6.66 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $537,087 - $629,179	5,836 New	5,836 $620,000
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $1.79 Million - $2.34 Million	-24,681 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $1.97 Million - $2.62 Million	24,681 New	24,681 $2.1 Million
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $714,776 - $821,354	-8,294 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $741,732 - $848,227	8,294 New	8,294 $807,000
Q1 2021 May 13, 2021	SELL	$87.57 - $119.4 $637,772 - $869,590	-7,283 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$86.91 - $108.33 $1.69 Million - $2.11 Million	-19,462 Reduced 72.77%	7,283 $698,000
Q3 2020 Nov 06, 2020	BUY	$96.16 - $135.15 $2.57 Million - $3.61 Million	26,745 New	26,745 $2.57 Million
Q1 2020 May 08, 2020	SELL	$75.11 - $113.76 $3.81 Million - $5.77 Million	-50,763 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$86.8 - $118.57 $4.41 Million - $6.02 Million	50,763 New	50,763 $5.46 Million
Q3 2019 Nov 08, 2019	SELL	$83.82 - $101.5 $1.48 Million - $1.79 Million	-17,656 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$72.24 - $91.27 $273,717 - $345,822	-3,789 Reduced 17.67%	17,656 $1.49 Million
Q1 2019 May 13, 2019	BUY	$69.31 - $91.53 $1.49 Million - $1.96 Million	21,445 New	21,445 $1.89 Million
Q4 2018 Feb 13, 2019	SELL	$68.32 - $124.36 $1.16 Million - $2.11 Million	-16,980 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$98.88 - $125.85 $1.68 Million - $2.14 Million	16,980 New	16,980 $2.09 Million
Q2 2018 Aug 07, 2018	SELL	$75.3 - $105.99 $2.34 Million - $3.3 Million	-31,120 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$75.88 - $92.43 $2.13 Million - $2.6 Million	28,115 Added 935.61%	31,120 $2.58 Million
Q4 2017 Feb 09, 2018	SELL	$58.53 - $77.59 $59,349 - $78,676	-1,014 Reduced 25.23%	3,005 $233,000
Q3 2017 Nov 09, 2017	BUY	$47.97 - $61.28 $192,791 - $246,284	4,019	4,019 $246,000

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Neurocrine Biosciences Inc Transaction History